User:Syed Hassan Abbas Kazmi: Difference between revisions
Jump to navigation
Jump to search
| Line 50: | Line 50: | ||
* [[AHA/ASA guideline recommendations for of Early management of acute ischemic stroke|2018 AHA/ASA guidelines for management of acute ischemic stroke]] | * [[AHA/ASA guideline recommendations for of Early management of acute ischemic stroke|2018 AHA/ASA guidelines for management of acute ischemic stroke]] | ||
* [[Mechanical ventilation resident survival guide|Mechanical Ventilation Resident Survival Guide]] | * [[Mechanical ventilation resident survival guide|Mechanical Ventilation Resident Survival Guide]] | ||
* [[Deep vein thrombosis medical therapy]] | |||
* Drug page for Andexxa (Reversal agent for Factor Xa inhibitors- approved by FDA in May 2018) | * Drug page for Andexxa (Reversal agent for Factor Xa inhibitors- approved by FDA in May 2018) | ||
* [https://cardiologynownews.org/corevalve-evolut-r-and-edwards-sapien-3-valves-reveal-equivalence-in-transcatheter-aortic-valve-implantation-tavi-in-a-head-to-head-comparison/ Corevalve Evolut R (Medtronic) and Edwards Sapien 3 (Edward Lifesciences) Valves Reveal Equivalence in Transcatheter Aortic Valve Implantation (TAVI) in a Head-to-Head Comparison] | * [https://cardiologynownews.org/corevalve-evolut-r-and-edwards-sapien-3-valves-reveal-equivalence-in-transcatheter-aortic-valve-implantation-tavi-in-a-head-to-head-comparison/ Corevalve Evolut R (Medtronic) and Edwards Sapien 3 (Edward Lifesciences) Valves Reveal Equivalence in Transcatheter Aortic Valve Implantation (TAVI) in a Head-to-Head Comparison] | ||
Revision as of 16:09, 24 October 2018
Syed Hassan Abbas Kazmi
Syed Hassan Abbas Kazmi, B.Sc, M.D.
Contact:
Email: skazmi@bidmc.harvard.edu
Current Position
- Associate Editor-in-Chief, WikiDoc.org
- Postdoctoral Research Fellow, PERFUSE Study Group
Professional Background
Dr. Hassan Kazmi is currently working as a research fellow at Beth Israel Deaconess Medical Center, Harvard University in Boston, Massachusetts. He received his M.B;B.S. degree from the King Edward Medical University in Lahore, Pakistan, after which he was involved in research projects with Government College University, Lahore and at San Jose State University, San Jose. He then joined as a post-doctoral research fellow at PERFUSE Study Group. Dr. Kazmi is an associate editor-in-chief at WikiDoc.org, where he authors and peer-reviews content in Oncology, Cardiovascular medicine, Nephrology, Infectious disease, Gastroenterology, Hematology, Neurology, Pulmonary medicine and Endocrinology.
Education
- 2016 - M.D. and ECFMG Certification
- 2013 - M.B;B.S. Degree, King Edward Medical University, Lahore, Pakistan
- 2011 - Bachelor of Sciences Degree, University of Punjab, Lahore, Pakistan
Clinical Experience
- 2010-2012 - Clinical rotations , Mayo Hospital Lahore, Pakistan
- 2012 - Clinical rotations, Internal medicine and critical care departments, The Hospital of Central Connecticut, University of Connecticut (Uconn), USA
- 2013-2014 - Intern General Hospital Lahore, Pakistan
- 2014-2016 - Medical officer, Internal medicine department, Mayo Hospital Lahore, Pakistan
- 2016 - Extern Starling Physicians Group
- 2016 - Extern, Internal medicine department, Wilkes Regional Medical Center, Wilkesboro, North Carolina, USA
- 2017 - Extern, Cardiology, Heart and Vascular Institute (DMC), Dearborn/Southfield, Michigan, USA
Authored Pages
- Psoriasis
- Diabetic ketoacidosis (DKA)
- Alzheimer's disease
- Celiac disease
- Toxic shock syndrome
- Mucormycosis
- Dermatophytosis
- Whipworm infection
- Bourbon virus infection
- Sleep deprivation survey
- Conn's Syndrome
- Gastroesophageal varices
- Adult-onset Still’s disease
- Glomerulonephritis
- Nephrolithiasis
- Hematuria
- Venous Thromboembolism
- Down's Syndrome
- Urinary Incontinence
- Pathophysiology of Atrial Fibrillation
- Pathophysiology and molecular mechanisms of acute myeloid leukemia
- 2018 AHA/ASA guidelines for management of acute ischemic stroke
- Mechanical Ventilation Resident Survival Guide
- Deep vein thrombosis medical therapy
- Drug page for Andexxa (Reversal agent for Factor Xa inhibitors- approved by FDA in May 2018)
- Corevalve Evolut R (Medtronic) and Edwards Sapien 3 (Edward Lifesciences) Valves Reveal Equivalence in Transcatheter Aortic Valve Implantation (TAVI) in a Head-to-Head Comparison
- Polymer coated sustained-release Eluvia DES outshines non-polymer coated Zilver DES for femoropopliteal artery stenosis
- Dual Therapy Reduces Bleeding Compared with Triple Therapy in A-Fib after PCI
- ‘Lowest is best’ when it comes to blood LDL cholesterol levels (A meta-analysis shows lower blood LDL cholesterol levels may be efficacious and safe)